Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate

Fertility and Sterility

Volumn 85, Issue 6, 2006, Pages 1761-1765

  Tulandi, Togas ^a   Martin, James ^b   Al Fadhli, Raedah ^a   Kabli, Nadia ^a   Forman, Rachel ^c   Hitkari, Jason ^c   Librach, Clifford ^c   Greenblatt, Ellen ^c   Casper, Robert F ^c  

^a MCGILL UNIVERSITY   (Canada)

^b Southern Ontario Fertility Technologies   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Aromatase inhibitor; birth defect; clomiphene; congenital anomalies; congenital cardiac anomaly; congenital heart disease; congenital malformation; infertility; letrozole; ovulation

Indexed keywords

CLOMIFENE CITRATE; LETROZOLE; METFORMIN; PROGESTERONE;

ADULT; ARTICLE; BIRTH WEIGHT; CANADA; CHROMOSOME ABERRATION; CLEFT PALATE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCEPTION; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CONGENITAL SKIN DISEASE; CONTROLLED STUDY; DOWN SYNDROME; ESOPHAGUS ATRESIA; FEMALE; FEMALE INFERTILITY; GREAT VESSELS TRANSPOSITION; HEART RIGHT VENTRICLE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYDROCELE; HYPOSPADIAS; INCIDENCE; INFERTILITY THERAPY; INGUINAL HERNIA; KIDNEY DISEASE; MATERNAL AGE; MEDICAL RECORD; MUSCLE HYPOTONIA; MUSCULAR DYSTROPHY; NEWBORN; OMPHALOCELE; PLAGIOCEPHALY; POLYDACTYLY; POTTER SYNDROME; PRIORITY JOURNAL; PROGENY; PTOSIS; PULMONARY VALVE ATRESIA; PYELECTASIS; RETROSPECTIVE STUDY; SYNDACTYLY; TRISOMY 18; UMBILICAL HERNIA;

ABNORMALITIES; ADULT; AROMATASE INHIBITORS; CANADA; CLOMIPHENE; COMORBIDITY; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFERTILITY, FEMALE; NITRILES; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; TRIAZOLES;

EID: 33744541255     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.03.014     Document Type: Article

References (19)

1. Holzer H., Casper R., and Tulandi T. A new era of ovulation induction. Fertil Steril 85 (2006) 277-284
2. Mitwally M.F., and Casper R.F. Use of an aromatase inhibitor for induction of ovulation in cases of inadequate response to clomiphene citrate. Fertil Steril 75 (2001) 305-309
3. Biljan M.M., Hemmings R., and Brassard N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Steril 84 supp.1 (2005) O-231 Abstract 1033
4. Fontana PG, Leclerc JM. Contraindication of Femara® (letrozole) in premenopausal women. http://www.ca.novartis.com/downloads/en/letters/femara_hcp_e_17_11_05.pdf.
5. World Health Organization, International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Version for 2003, Chapter XVII, Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99). http://www3.who.int/icd/vol1htm2003/fr-icd.htm.
6. nd edition, Chapter 13. Prenatal Diagnosis and Fetal Therapy (2005), McGraw-Hill Professional, New York
7. Health Canada. Congenital Anomalies in Canada - A Perinatal Health Report (2002). http://www.phac-aspc.gc.ca/publicat/cac-acc02 http://www.phac-aspc.gc.ca/publicat/cac-acc02.
8. Correy J.F., Marsden D.E., and Schokman F.C. The outcome of pregnancy resulting from clomiphene-induced ovulation. Aust N Zealand J Obstet Gynaecol 22 (1982) 18-21
9. Schenker J.G., Yarkoni S., and Granat M. Multiple pregnancies following induction of ovulation. Fertil Steril 35 (1981) 105-123
10. Whiteman D., Murphy M., Hey K., O'Donnell M., and Goldacre M. Reproductive factors, subfertility, and risk of neural tube defects. a case-control study based on the Oxford Record Linkage Study Register. Am J Epidemiol 152 (2000) 823-828
11. Carlier P., Choulika S., and Efthymiou M.L. Clomiphene-exposed pregnancies-analysis of 39 information requests including 25 cases with known outcome. Therapie 51 (1996) 532-536
12. FDA Use-in-Pregnancy Ratings. http://www.perinatology.com/exposures/Drugs/FDACategories.htm
13. Stephensen S.S., Sigfusson G., Eiriksson H., Sverrisson J.T., Torfason B., Haraldsson A., and Helgason H. Congenital cardiac malformations in Iceland from 1990 through 1999. Cardiol in the Young 14 (2004) 396-401
14. Wren C., Richmond S., and Donaldson L. Presentation of congenital heart disease in infancy. implications for routine examination. Arch Dis Child Fetal Neonatal Ed 80 (1999) F44-F53
15. Bower C., and Ramsay J.M. Congenital heart disease. a 10 year cohort. J Pediatr Child Health 30 (1994) 414-418
16. Samson G.R., and Kumar S.R. A study of congenital cardiac disease in a neonatal population-the validity of echocardiography undertaken by a neonatologist. Cardiol in the Young 14 (2004) 585-593
17. Hoffman J.I.E. Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol 16 (1995) 103-113
18. Buckett W.M., and Tan S.L. Congenital abnormalities in children born after assisted reproductive techniques. how much is associated with the presence of infertility and how much with its treatment?. Fertil Steril 84 (2005) 1318-1319
19. Shepard T.H. Catalog of Teratogenic Agents. 10th ed (2001), Johns Hopkins University Press, Baltimore